Annual SGA
$87.74 M
+$8.05 M+10.10%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual SGA is $87.74 million, with the most recent change of +$8.05 million (+10.10%) on December 31, 2023.
- During the last 3 years, MCRB annual SGA has risen by +$56.97 million (+185.11%).
- MCRB annual SGA is now at all-time high.
Performance
MCRB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$12.71 M
-$3.35 M-20.85%
September 30, 2024
Summary
- As of February 7, 2025, MCRB quarterly SGA is $12.71 million, with the most recent change of -$3.35 million (-20.85%) on September 30, 2024.
- Over the past year, MCRB quarterly SGA has dropped by -$11.52 million (-47.53%).
- MCRB quarterly SGA is now -54.69% below its all-time high of $28.05 million, reached on June 30, 2023.
Performance
MCRB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.01 B
-$25.48 M-0.64%
September 30, 2024
Summary
- As of February 7, 2025, MCRB TTM SGA is -$4.01 billion, with the most recent change of -$25.48 million (-0.64%) on September 30, 2024.
- Over the past year, MCRB TTM SGA has dropped by -$4.10 billion (-4358.22%).
- MCRB TTM SGA is now -14308.96% below its all-time high of -$27.83 million.
Performance
MCRB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MCRB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | -47.5% | -4358.2% |
| 3 y3 years | +185.1% | -43.3% | -5132.1% |
| 5 y5 years | +169.2% | -43.3% | -5132.1% |
MCRB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.7% | -54.7% | at low | -67.4% | at low |
| 5 y | 5-year | at high | +254.6% | -54.7% | +119.8% | -130.7% | at low |
| alltime | all time | at high | +9078.2% | -54.7% | +2675.1% | <-9999.0% | at low |
Seres Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.71 M(-20.9%) | $68.46 M(-8.9%) |
| Jun 2024 | - | $16.06 M(+3.8%) | $75.18 M(-13.8%) |
| Mar 2024 | - | $15.47 M(-36.2%) | $87.17 M(-7.4%) |
| Dec 2023 | $87.74 M(+10.1%) | $24.23 M(+24.7%) | $94.18 M(+2.0%) |
| Sep 2023 | - | $19.43 M(-30.7%) | $92.36 M(+1.1%) |
| Jun 2023 | - | $28.05 M(+24.8%) | $91.31 M(+9.2%) |
| Mar 2023 | - | $22.47 M(+0.3%) | $83.59 M(+4.9%) |
| Dec 2022 | $79.69 M(+15.1%) | $22.40 M(+21.9%) | $79.69 M(+2.4%) |
| Sep 2022 | - | $18.38 M(-9.6%) | $77.80 M(-1.5%) |
| Jun 2022 | - | $20.34 M(+9.5%) | $78.97 M(+3.8%) |
| Mar 2022 | - | $18.57 M(-9.4%) | $76.09 M(+9.9%) |
| Dec 2021 | $69.26 M(+125.1%) | $20.51 M(+4.8%) | $69.26 M(+16.7%) |
| Sep 2021 | - | $19.56 M(+12.1%) | $59.35 M(+25.4%) |
| Jun 2021 | - | $17.45 M(+48.6%) | $47.34 M(+30.1%) |
| Mar 2021 | - | $11.74 M(+10.8%) | $36.38 M(+18.2%) |
| Dec 2020 | $30.77 M(+24.4%) | $10.60 M(+40.3%) | $30.77 M(+18.5%) |
| Sep 2020 | - | $7.55 M(+16.3%) | $25.96 M(+6.8%) |
| Jun 2020 | - | $6.49 M(+5.8%) | $24.31 M(+3.9%) |
| Mar 2020 | - | $6.14 M(+6.2%) | $23.39 M(-5.5%) |
| Dec 2019 | $24.75 M | $5.78 M(-2.0%) | $24.75 M(-6.6%) |
| Sep 2019 | - | $5.90 M(+5.8%) | $26.50 M(-6.0%) |
| Jun 2019 | - | $5.57 M(-25.6%) | $28.19 M(-10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $7.50 M(-0.5%) | $31.31 M(-3.9%) |
| Dec 2018 | $32.60 M(-4.2%) | $7.53 M(-0.8%) | $32.60 M(-3.7%) |
| Sep 2018 | - | $7.59 M(-12.7%) | $33.85 M(-1.5%) |
| Jun 2018 | - | $8.70 M(-0.9%) | $34.38 M(+1.0%) |
| Mar 2018 | - | $8.78 M(-0.1%) | $34.05 M(+0.0%) |
| Dec 2017 | $34.04 M(+4.4%) | $8.79 M(+8.3%) | $34.04 M(+1.0%) |
| Sep 2017 | - | $8.12 M(-3.0%) | $33.70 M(+0.5%) |
| Jun 2017 | - | $8.37 M(-4.5%) | $33.55 M(-1.8%) |
| Mar 2017 | - | $8.76 M(+3.7%) | $34.15 M(+4.8%) |
| Dec 2016 | $32.62 M(+94.6%) | $8.45 M(+6.1%) | $32.60 M(+8.5%) |
| Sep 2016 | - | $7.97 M(-11.2%) | $30.04 M(+12.2%) |
| Jun 2016 | - | $8.97 M(+24.4%) | $26.78 M(+25.3%) |
| Mar 2016 | - | $7.21 M(+22.5%) | $21.36 M(+27.5%) |
| Dec 2015 | $16.76 M(+284.1%) | $5.89 M(+25.0%) | $16.76 M(+28.7%) |
| Sep 2015 | - | $4.71 M(+32.5%) | $13.03 M(+38.2%) |
| Jun 2015 | - | $3.56 M(+36.5%) | $9.43 M(+48.9%) |
| Mar 2015 | - | $2.61 M(+21.0%) | $6.33 M(+45.1%) |
| Dec 2014 | $4.36 M(+250.0%) | $2.15 M(+93.4%) | $4.36 M(+97.4%) |
| Sep 2014 | - | $1.11 M(+143.0%) | $2.21 M(+101.4%) |
| Jun 2014 | - | $458.00 K(-28.4%) | $1.10 M(+71.6%) |
| Mar 2014 | - | $640.00 K | $640.00 K |
| Dec 2013 | $1.25 M(+30.4%) | - | - |
| Dec 2012 | $956.00 K | - | - |
FAQ
- What is Seres Therapeutics annual SGA?
- What is the all time high annual SGA for Seres Therapeutics?
- What is Seres Therapeutics annual SGA year-on-year change?
- What is Seres Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Seres Therapeutics?
- What is Seres Therapeutics quarterly SGA year-on-year change?
- What is Seres Therapeutics TTM SGA?
- What is the all time high TTM SGA for Seres Therapeutics?
- What is Seres Therapeutics TTM SGA year-on-year change?
What is Seres Therapeutics annual SGA?
The current annual SGA of MCRB is $87.74 M
What is the all time high annual SGA for Seres Therapeutics?
Seres Therapeutics all-time high annual SGA is $87.74 M
What is Seres Therapeutics annual SGA year-on-year change?
Over the past year, MCRB annual SGA has changed by +$8.05 M (+10.10%)
What is Seres Therapeutics quarterly SGA?
The current quarterly SGA of MCRB is $12.71 M
What is the all time high quarterly SGA for Seres Therapeutics?
Seres Therapeutics all-time high quarterly SGA is $28.05 M
What is Seres Therapeutics quarterly SGA year-on-year change?
Over the past year, MCRB quarterly SGA has changed by -$11.52 M (-47.53%)
What is Seres Therapeutics TTM SGA?
The current TTM SGA of MCRB is -$4.01 B
What is the all time high TTM SGA for Seres Therapeutics?
Seres Therapeutics all-time high TTM SGA is -$27.83 M
What is Seres Therapeutics TTM SGA year-on-year change?
Over the past year, MCRB TTM SGA has changed by -$4.10 B (-4358.22%)